ENTITY
Acadia Pharmaceuticals

Acadia Pharmaceuticals (ACAD US)

23
Analysis
Health CareUnited States
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.
more
Company Presentation18 Nov 2025 16:30
Company Presentation06 Nov 2025 05:30
Company Presentation07 Aug 2025 04:30
Company Presentation27 Feb 2018 20:00
Company Presentation25 Jun 2025 20:30
x